Analysen zu Novo Nordisk
| 03.07.25 | Novo Nordisk Buy | UBS AG | |
| 01.07.25 | Novo Nordisk Buy | UBS AG | |
| 30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | Novo Nordisk Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.25 | Novo Nordisk Buy | UBS AG | |
| 23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
| 23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.25 | Novo Nordisk Buy | UBS AG | |
| 17.06.25 | Novo Nordisk Buy | UBS AG | |
| 16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.06.25 | Novo Nordisk Buy | UBS AG | |
| 09.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.06.25 | Novo Nordisk Buy | UBS AG | |
| 02.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.05.25 | Novo Nordisk Buy | UBS AG | |
| 19.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 09.05.25 | Novo Nordisk Buy | UBS AG | |
| 08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | UBS AG | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 24.03.25 | Novo Nordisk Buy | Deutsche Bank AG |
Aktuelle Aktienanalysen
| 26.11.25 | ams kaufen | Deutsche Bank AG | |
| 26.11.25 | ASML NV Equal Weight | Barclays Capital | |
| 26.11.25 | L'Oréal Underweight | Barclays Capital | |
| 26.11.25 | voestalpine kaufen | Deutsche Bank AG | |
| 26.11.25 | PATRIZIA Buy | Warburg Research | |
| 26.11.25 | NVIDIA Outperform | Bernstein Research | |
| 26.11.25 | Aroundtown Underweight | Barclays Capital | |
| 26.11.25 | Aroundtown Underperform | Jefferies & Company Inc. | |
| 26.11.25 | ArcelorMittal Buy | Deutsche Bank AG | |
| 26.11.25 | Salzgitter Buy | Deutsche Bank AG | |
| 26.11.25 | TKMS thyssenkrupp Marine Systems Buy | Deutsche Bank AG | |
| 26.11.25 | Vestas Wind Systems A-S Outperform | Bernstein Research | |
| 26.11.25 | L'Oréal Neutral | UBS AG | |
| 26.11.25 | thyssenkrupp nucera Neutral | Goldman Sachs Group Inc. | |
| 26.11.25 | Siemens Energy Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.11.25 | DHL Group Neutral | UBS AG | |
| 26.11.25 | 1&1 Equal Weight | Barclays Capital | |
| 26.11.25 | United Internet Equal Weight | Barclays Capital | |
| 26.11.25 | Ferrari Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | TRATON Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Valeo Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Renault Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Stabilus Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Porsche vz. Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | BAT Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Danone Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Aumovio Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Volkswagen Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | BMW Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | L'Oréal Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Mercedes-Benz Group Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Beiersdorf Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Eni Buy | UBS AG | |
| 26.11.25 | Shell Neutral | UBS AG | |
| 26.11.25 | Schaeffler Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Michelin Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Continental Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Daimler Truck Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Pernod Ricard Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | RENK Overweight | JP Morgan Chase & Co. | |
| 26.11.25 | Henkel vz. Underweight | JP Morgan Chase & Co. | |
| 25.11.25 | L'Oréal Outperform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.